Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular Diversity
Vanessa Almendro(Danaher (United States)), Kornélia Polyák(Dana-Farber Cancer Institute), Reo Maruyama(Brigham and Women's Hospital), Xavier González(Breast Cancer Research Foundation), Yu-Kang Cheng(Harvard University), Alexander van Oudenaarden(Royal Netherlands Academy of Arts and Sciences), Shalev Itzkovitz(Weizmann Institute of Science), Hege G. Russnes(Oslo University Hospital), Robin L. Jones(Institute of Cancer Research), Mithat Gönen(Memorial Sloan Kettering Cancer Center), Åslaug Helland(Oslo University Hospital), Pere Gascón(Merck KGaA, Darmstadt (Germany)), Amanda Randles(Duke University), Mitch Dowsett(Institute of Cancer Research), Elisabet Ametller(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Jorge S. Reis‐Filho(AstraZeneca (France)), Franziska Michor(Dana-Farber Cancer Institute), Anne‐Lise Børresen‐Dale(Oslo University Hospital), Inga Hansine Rye(Oslo University Hospital), Montse Muñoz(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Andriy Marusyk(Moffitt Cancer Center)
Cited by 283
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
|Nature reviews. Cancer|2009|3.3k